Annual Net Income
-$74.68 M
+$65.00 M+46.54%
December 31, 2024
Summary
- As of March 12, 2025, ITCI annual net profit is -$74.68 million, with the most recent change of +$65.00 million (+46.54%) on December 31, 2024.
- During the last 3 years, ITCI annual net income has risen by +$209.45 million (+73.72%).
- ITCI annual net income is now -350.10% below its all-time high of -$16.59 million, reached on December 31, 2012.
Performance
ITCI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$16.89 M
+$9.44 M+35.86%
December 1, 2024
Summary
- As of March 12, 2025, ITCI quarterly net profit is -$16.89 million, with the most recent change of +$9.44 million (+35.86%) on December 1, 2024.
- Over the past year, ITCI quarterly net income has stayed the same.
- ITCI quarterly net income is now -154808.26% below its all-time high of -$10.90 thousand, reached on June 30, 2013.
Performance
ITCI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$74.68 M
+$11.69 M+13.54%
December 1, 2024
Summary
- As of March 12, 2025, ITCI TTM net profit is -$74.68 million, with the most recent change of +$11.69 million (+13.54%) on December 1, 2024.
- Over the past year, ITCI TTM net income has stayed the same.
- ITCI TTM net income is now -685000.92% below its all-time high of -$10.90 thousand, reached on June 30, 2013.
Performance
ITCI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ITCI Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.5% | 0.0% | 0.0% |
| 3 y3 years | +73.7% | +30.4% | +51.9% |
| 5 y5 years | +49.5% | +30.4% | +51.9% |
ITCI Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.7% | -10.7% | +80.5% | at high | +76.8% |
| 5 y | 5-year | at high | +73.7% | -10.7% | +80.5% | at high | +76.8% |
| alltime | all time | -350.1% | +73.7% | <-9999.0% | +80.5% | <-9999.0% | +76.8% |
Intra-Cellular Therapies Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$74.68 M(-46.5%) | - | - |
| Dec 2024 | - | -$16.89 M(-35.9%) | -$74.68 M(-13.5%) |
| Sep 2024 | - | -$26.32 M(+62.3%) | -$86.37 M(+2.5%) |
| Jun 2024 | - | -$16.22 M(+6.4%) | -$84.30 M(-24.0%) |
| Mar 2024 | - | -$15.25 M(-46.6%) | -$110.87 M(-20.6%) |
| Dec 2023 | -$139.67 M(-45.5%) | -$28.58 M(+17.8%) | -$139.67 M(-10.0%) |
| Sep 2023 | - | -$24.26 M(-43.3%) | -$155.12 M(-15.9%) |
| Jun 2023 | - | -$42.78 M(-2.9%) | -$184.37 M(-19.2%) |
| Mar 2023 | - | -$44.05 M(+0.1%) | -$228.19 M(-11.0%) |
| Dec 2022 | -$256.26 M(-9.8%) | -$44.03 M(-17.7%) | -$256.26 M(-14.0%) |
| Sep 2022 | - | -$53.51 M(-38.2%) | -$297.96 M(-7.3%) |
| Jun 2022 | - | -$86.60 M(+20.1%) | -$321.36 M(+5.9%) |
| Mar 2022 | - | -$72.12 M(-15.9%) | -$303.50 M(+6.8%) |
| Dec 2021 | -$284.13 M(+25.2%) | -$85.73 M(+11.5%) | -$284.13 M(+9.7%) |
| Sep 2021 | - | -$76.91 M(+11.9%) | -$259.09 M(+9.2%) |
| Jun 2021 | - | -$68.74 M(+30.3%) | -$237.37 M(+2.2%) |
| Mar 2021 | - | -$52.74 M(-13.1%) | -$232.34 M(+2.3%) |
| Dec 2020 | -$227.01 M(+53.7%) | -$60.70 M(+10.0%) | -$227.01 M(+9.7%) |
| Sep 2020 | - | -$55.18 M(-13.4%) | -$206.89 M(+10.9%) |
| Jun 2020 | - | -$63.71 M(+34.4%) | -$186.57 M(+16.4%) |
| Mar 2020 | - | -$47.41 M(+16.8%) | -$160.30 M(+8.5%) |
| Dec 2019 | -$147.72 M | -$40.58 M(+16.4%) | -$147.72 M(-0.1%) |
| Sep 2019 | - | -$34.86 M(-6.9%) | -$147.89 M(-4.3%) |
| Jun 2019 | - | -$37.44 M(+7.5%) | -$154.55 M(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$34.84 M(-14.5%) | -$154.48 M(-0.4%) |
| Dec 2018 | -$155.13 M(+58.7%) | -$40.75 M(-1.9%) | -$155.13 M(+7.3%) |
| Sep 2018 | - | -$41.52 M(+11.1%) | -$144.59 M(+14.8%) |
| Jun 2018 | - | -$37.38 M(+5.3%) | -$125.94 M(+18.4%) |
| Mar 2018 | - | -$35.48 M(+17.4%) | -$106.32 M(+8.7%) |
| Dec 2017 | -$97.77 M(-16.0%) | -$30.21 M(+32.1%) | -$97.77 M(+2.9%) |
| Sep 2017 | - | -$22.87 M(+28.8%) | -$95.05 M(-7.2%) |
| Jun 2017 | - | -$17.76 M(-34.1%) | -$102.44 M(-11.3%) |
| Mar 2017 | - | -$26.93 M(-2.0%) | -$115.52 M(-0.8%) |
| Dec 2016 | -$116.43 M(+11.1%) | -$27.48 M(-9.2%) | -$116.43 M(-1.1%) |
| Sep 2016 | - | -$30.27 M(-1.8%) | -$117.78 M(-1.6%) |
| Jun 2016 | - | -$30.83 M(+10.8%) | -$119.67 M(+8.4%) |
| Mar 2016 | - | -$27.84 M(-3.4%) | -$110.35 M(+5.3%) |
| Dec 2015 | -$104.79 M(+241.4%) | -$28.83 M(-10.3%) | -$104.79 M(+15.0%) |
| Sep 2015 | - | -$32.16 M(+49.5%) | -$91.16 M(+39.4%) |
| Jun 2015 | - | -$21.51 M(-3.5%) | -$65.41 M(+35.1%) |
| Mar 2015 | - | -$22.29 M(+46.6%) | -$48.43 M(+57.8%) |
| Dec 2014 | -$30.69 M(+14.2%) | -$15.20 M(+136.9%) | -$30.69 M(+30.4%) |
| Sep 2014 | - | -$6.42 M(+41.5%) | -$23.53 M(+6.8%) |
| Jun 2014 | - | -$4.53 M(-0.2%) | -$22.03 M(+25.8%) |
| Mar 2014 | - | -$4.54 M(-43.5%) | -$17.51 M(+35.0%) |
| Dec 2013 | -$26.87 M(+61.9%) | -$8.04 M(+63.7%) | -$12.96 M(+163.3%) |
| Sep 2013 | - | -$4.91 M(>+9900.0%) | -$4.92 M(>+9900.0%) |
| Jun 2013 | - | -$10.90 K | -$10.90 K |
| Dec 2012 | -$16.59 M | - | - |
FAQ
- What is Intra-Cellular Therapies annual net profit?
- What is the all time high annual net income for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual net income year-on-year change?
- What is Intra-Cellular Therapies quarterly net profit?
- What is the all time high quarterly net income for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly net income year-on-year change?
- What is Intra-Cellular Therapies TTM net profit?
- What is the all time high TTM net income for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies TTM net income year-on-year change?
What is Intra-Cellular Therapies annual net profit?
The current annual net income of ITCI is -$74.68 M
What is the all time high annual net income for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual net profit is -$16.59 M
What is Intra-Cellular Therapies annual net income year-on-year change?
Over the past year, ITCI annual net profit has changed by +$65.00 M (+46.54%)
What is Intra-Cellular Therapies quarterly net profit?
The current quarterly net income of ITCI is -$16.89 M
What is the all time high quarterly net income for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly net profit is -$10.90 K
What is Intra-Cellular Therapies quarterly net income year-on-year change?
Over the past year, ITCI quarterly net profit has changed by $0.00 (0.00%)
What is Intra-Cellular Therapies TTM net profit?
The current TTM net income of ITCI is -$74.68 M
What is the all time high TTM net income for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high TTM net profit is -$10.90 K
What is Intra-Cellular Therapies TTM net income year-on-year change?
Over the past year, ITCI TTM net profit has changed by $0.00 (0.00%)